There was this very embarrassing day around year six of my career as a statistician working in clinical trials. I had a small group of interns working on a project that combined data from multiple clinical trials. The goal was to better understand sources of variation in the common control
Collecting, managing, standardizing and analyzing clinical data during (and after) a clinical trial is crucial in the process for submission and regulatory approval of a new compound, biological, device or other therapy. A central clinical platform requires: Robust and auditable analytics to prove the result to the authorities and external
SAS is widely used in clinical research activities including: Managing and transforming data. Generating tabular and graphical summaries. Performing powerful statistical analyses such as safety and efficacy evaluations. In addition, SAS provides a number of interfaces from which a user can select to work with the data. One of these
In my previous post, I wrote about the Quick Pulse survey of leaders of health care institutions and the vital role data and analytics has in patient care and engagement. In this post, I'll tell you what the survey had to say about the progress these leaders believe they are
Everyone in health care is talking about data and analytics these days and the vendor world has shifted into overdrive. So what is really going on in the trenches, and what does this mean for the future? Does this mean that we will finally find the holy grail of information-driven
Medicare payment changes are coming. The Centers for Medicare and Medicaid Services (CMS) has announced the intention of increasing the proportion of payments to providers based on outcomes and changes in health status, as opposed to delivery of services. At the January 11th, 2016 J.P. Morgan Annual Health Care Conference,
Health care is undergoing exponential change, and this year we’ll continue to see the industry launch bold missions to improve the patient experience. With new types of data and technologies, the vision of making health care more personalized and proactive is becoming closer to reality. In my new book “The
PharmaVOICE recently published an article: Analytics Driven Marketing for the pharmaceutical industry and I was fortunate enough to be interviewed. The article discusses the increased use of advanced analytics to make better marketing decisions, the progress that has been made and the challenges that still need to be overcome. Within
Earlier this month I attended my first Forbes Healthcare Summit, where the stated goal for this year was to “figure out how to create the kind of care we know we deserve.” The event offered a unique gathering of pharmaceutical, health care and biotechnology chief executives engaged in frank discussions
We have all heard many times about how much the US spends on health care each year. But let’s hear it again . . . because it is staggering: According to Centers for Medicare and Medicaid Services (CMS), in 2013, the national health expenditure (NHE) grew to $2.9 trillion. That
The high cost of pricing myopia When launching a pharmaceutical product, it’s not enough to negotiate the best reimbursable price for each local market. Overall financial performance will depend on successfully managing go-to-market strategies at the global level. That means determining the optimal price and launch sequence for all the
Healthcare IT News recently published an article on 18 health technologies poised for big growth, a list culled from a HIMSS database. The database is used to track an extensive list of technology products that have seen growth of 4-10 percent since 2010, but have not yet reached a 70
“The most successful life sciences companies will be the ones that can convince their customers – patients, health care professionals, government authorities and health plans – that new treatments are the most effective and provide true value compared with alternatives.” Jamie Powers, DrPH, Principal Consultant and Practice Lead, SAS Health
The move to value-based payments is well underway and accelerating. The shift is putting unprecedented pressure on health care providers to better manage the cost and quality of care they deliver. Who will have a much better shot of success? Organizations that understand how well they are performing, where they have opportunities to improve
A recent news headline read, “Bipartisan committee wants government-subsidized electronic records systems scrutinized for ‘information blocking.’” * The question before the US Senate Appropriations Committee is whether taxpayer-funded EHR software solutions are now preventing the unrestricted exchange of medical records between health care organizations. If this is in fact the case,
